Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo

DiLillo, David J, Tan, Gene S, Palese, Peter, Ravetch, Jeffrey V·2014·Nature Medicine

DOI 10.1038/nm.3443

Cited by (763)

Items 301–400 of 763

T and B Cell Immune Responses to Influenza Viruses in Pigs
Barbara Holzer, Veronica Martini, Matthew D. Edmans, Elma Z. Tchilian · 2019 · Frontiers in Immunology
Chimeric hemagglutinin vaccine elicits broadly protective CD4 and CD8 T cell responses against multiple influenza strains and subtypes
Hsin-Yu Liao, Shih-Chi Wang, Yi‐An Ko, Kuo‐I Lin, Che Ma, Ting-Jen Rachel Cheng, Chi‐Huey Wong · 2020 · Proceedings of the National Academy of Sciences
Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections
Shamus P. Keeler, Julie M. Fox · 2021 · Viruses
A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice
Masayuki Kuraoka, Clare Burn Aschner, Ian W. Windsor, Aakash Mahant Mahant, S. Garforth, Susan Kong, Jacqueline M. Achkar, Steven C. Almo, Garnett H. Kelsoe, Betsy C. Herold · 2022 · Journal of Clinical Investigation
Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th Cells
Michael Storcksdieck genannt Bonsmann, Thomas Niezold, Vladimir Temchura, Franco Pissani, Katrin Ehrhardt, Eric P. Brown, Nana Yaw Osei‐Owusu, Drew Hannaman, Hartmut Hengel, Margaret E. Ackerman et al. · 2015 · The Journal of Immunology
Antibody-Dependent Cell-Mediated Cytotoxicity Epitopes on the Hemagglutinin Head Region of Pandemic H1N1 Influenza Virus Play Detrimental Roles in H1N1-Infected Mice
Zi‐Wei Ye, Shuofeng Yuan, Vincent Kwok‐Man Poon, Lei Wen, Dong Yang, Zehua Sun, Cun Li, Hu Meng, Huiping Shuai, Jie Zhou et al. · 2017 · Frontiers in Immunology
The Role of Fc Gamma Receptors in Broad Protection against Influenza Viruses
Natalie K. Thulin, Taia T. Wang · 2018 · Vaccines
Effector function does not contribute to protection from virus challenge by a highly potent HIV broadly neutralizing antibody in nonhuman primates
Lars Hangartner, David Beauparlant, Eva G. Rakasz, Rebecca Nedellec, Nathanaël Hozé, Katherine R. McKenney, Maurício A. Martins, Gemma E. Seabright, Joel D. Allen, Andrea M. Weiler et al. · 2021 · Science Translational Medicine
Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice
Alec W. Freyn, Matthew Pine, Victoria C. Rosado, Marcel Benz, Hiromi Muramatsu, Mitchell B. Beattie, Ying K. Tam, Florian Krammer, Peter Palese, Raffael Nachbagauer et al. · 2021 · Molecular Therapy — Methods & Clinical Development
Humanized Mice to Study FcγR Function
Stylianos Bournazos, David J. DiLillo, Jeffrey V. Ravetch · 2014 · Current topics in microbiology and immunology
Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice
Eduard Puente‐Massaguer, Kirill Vasilev, A. Beyer, Madhumathi Loganathan, Benjamin Francis, Michael J. Scherm, Guha Asthagiri Arunkumar, Irene González‐Domínguez, Xueyong Zhu, Ian A. Wilson et al. · 2023 · Science Advances
Crystal Structure of a Homogeneous IgG-Fc Glycoform with the N-Glycan Designed to Maximize the Antibody Dependent Cellular Cytotoxicity
Chia-Lin Chen, Jen-Chi Hsu, Chin‐Wei Lin, Chia-Hung Wang, Ming-Hung Tsai, Chung‐Yi Wu, Chi‐Huey Wong, Che Ma · 2017 · ACS Chemical Biology
The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza
Amber M. Smith, Victor C. Huber · 2017 · Viral Immunology
Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo
Suzanne L. Epstein · 2018 · American Journal of Epidemiology
Leveraging Antibody, B Cell and Fc Receptor Interactions to Understand Heterogeneous Immune Responses in Tuberculosis
Stephen M. Carpenter, Lenette L. Lu · 2022 · Frontiers in Immunology
Current Landscape of Antiviral Drug Discovery
Wade S. Blair, Christopher D. Cox · 2016 · F1000Research
In Vivo Imaging of Influenza Virus Infection in Immunized Mice
Rita Czakó, Leatrice Vogel, Elaine W. Lamirande, Kevin W. Bock, Ian N. Moore, Ali H. Ellebedy, Rafi Ahmed, Andrew Mehle, Kanta Subbarao · 2017 · mBio
Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy
John R. Gallagher, Dustin M. McCraw, Udana Torian, Neetu M. Gulati, Mallory L. Myers, Michael T. Conlon, Audray K. Harris · 2018 · Vaccines
Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
Wei Dong, Yoshita C. Bhide, Federica Sicca, Tjarko Meijerhof, Kate A. Guilfoyle, Othmar G. Engelhardt, Louis Boon, Cornelis A. M. de Haan, George Carnell, Nigel James Temperton et al. · 2018 · Frontiers in Immunology
A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cells
Yi‐An Ko, Yueh‐Hsiang Yu, Yen-Fei Wu, Yung-Chieh Tseng, Chia-Lin Chen, King-Siang Goh, Hsin-Yu Liao, Ting-Hua Chen, Ting-Jen Rachel Cheng, An‐Suei Yang et al. · 2021 · PLoS Pathogens
Measuring the neutralization potency of influenza A virus hemagglutinin stalk/stem-binding antibodies in polyclonal preparations by microneutralization assay
Wenqian He, Caitlin E. Mullarkey, Matthew S. Miller · 2015 · Methods
The Next Wave of Influenza Drugs
Megan L. Shaw · 2017 · ACS Infectious Diseases
Pre-existing heterosubtypic immunity provides a barrier to airborne transmission of influenza viruses
Valerie Le Sage, Jennifer E. Jones, Karen A. Kormuth, William J. Fitzsimmons, Eric M. Nturibi, Gabriella H. Padovani, Claudia P. Arevalo, Andrea J. French, Annika J. Avery, Richard V. Manivanh et al. · 2021 · PLoS Pathogens
Hierarchical sequence-affinity landscapes shape the evolution of breadth in an anti-influenza receptor binding site antibody
Angela M. Phillips, Daniel P. Maurer, Caelan Brooks, Thomas Dupic, Aaron G. Schmidt, Michael M. Desai · 2023 · eLife
Progress on adenovirus-vectored universal influenza vaccines
Kui Xiang, Ying Guan, Zhou Yan, Yan Shanshan, Lei Zhang, Hongjun Li, Sun Maosheng · 2015 · Human Vaccines & Immunotherapeutics
Enhancing dendritic cell activation and HIV vaccine effectiveness through nanoparticle vaccination
Joshua J. Glass, Stephen John Kent, Robert De Rose · 2016 · Expert Review of Vaccines
Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection
Steven P. Rockman, Sue Lowther, Sarina Camuglia, Kirsten L. Vandenberg, Shirley Taylor, Louis Fabri, Sylvia Miescher, Martin J. Pearse, Deborah Middleton, Stephen John Kent et al. · 2017 · EBioMedicine
Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth
Yu Qiu, Svetlana S. Stegalkina, Jianxin Zhang, Ekaterina Boudanova, Anna Park, Yanfeng Zhou, Ponraj Prabakaran, Svetlana O. Pougatcheva, Irina V. Ustyugova, Thorsten U. Vogel et al. · 2019 · Journal of Virology
Airway Delivery of Anti-influenza Monoclonal Antibodies Results in Enhanced Antiviral Activities and Enables Broad-Coverage Combination Therapies
Adam Vigil, Natalia Frias‐Staheli, Teresa Carabeo, Michael G. Wittekind · 2020 · Journal of Virology
Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens?
Wei Zhan, Manish Muhuri, Phillip W.L. Tai, Guangping Gao · 2021 · Frontiers in Immunology
A chimeric thermostable M2e and H3 stalk-based universal influenza A virus vaccine
Subbiah Jeeva, Judy Oh, Ki‐Hye Kim, Chong Hyun Shin, Bo Ryoung Park, Noopur Bhatnagar, Baik Lin Seong, Bao‐Zhong Wang, Sang‐Moo Kang · 2022 · npj Vaccines
Adeno‐associated virus‐vectored influenza vaccine elicits neutralizing and Fcγ receptor‐activating antibodies
Daniel E Demminger, Lisa Walz, Kristina Dietert, Helen Hoffmann, Oliver Planz, Achim Dieter Gruber, Veronika von Messling, Thorsten Wolff · 2020 · EMBO Molecular Medicine
Beyond clinical trials: Evolutionary and epidemiological considerations for development of a universal influenza vaccine
Cecile G. Viboud, Katelyn M. Gostic, Martha I. Nelson, Graeme E. Price, Amanda C. Perofsky, Kaiyuan Sun, Nídia Sequeira Trovão, Benjamin John Cowling, Suzanne L. Epstein, David J. Spiro · 2020 · PLoS Pathogens
The Next Generation of Influenza Vaccines: Towards a Universal Solution
Christopher L. D. McMillan, Paul R. Young, Daniel Watterson, Keith Joseph Chappell · 2021 · Vaccines
Immunological perspectives on spatial and temporal vaccine delivery
Mingzhao Zhu · 2021 · Advanced Drug Delivery Reviews
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates
Andris Kazāks, I‐Na Lu, Sophie Farinelle, Alex Ramirez, Vincenzo Crescente, Benjamin A. F. Bláha, Olotu W. Ogonah, Tarit Mukhopadhyay, Mapi Perez de Obanos, Alejandro R.D. Krimer et al. · 2017 · BMC Biotechnology
Broadly protective influenza vaccines: design and production platforms
Husni Elbahesh, Giulietta Saletti, Thomas H. Gerlach, Guus F. Rimmelzwaan · 2018 · Current Opinion in Virology
Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
Emma Richelle Job, Tine Ysenbaert, Anne-Sophie de Smet, Annelies Van Hecke, Leander Meuris, Harry Kleanthous, Xavier Saelens, Thorsten U. Vogel · 2019 · mBio
Antibody-mediated NK cell activation as a correlate of immunity against influenza infection
Carolyn M. Boudreau, John S. Burke, Ashraf Siddig Yousif, Maya Sangesland, Sandra L. Jastrzebski, Chris P. Verschoor, George A. Kuchel, Daniel Lingwood, Harry Kleanthous, Iris De Bruijn et al. · 2023 · Nature Communications
Protection From Influenza by Intramuscular Gene Vector Delivery of a Broadly Neutralizing Nanobody Does Not Depend on Antibody Dependent Cellular Cytotoxicity
Joanne Marie M. Del Rosario, Matthew D. Smith, Kam Zaki, Paul Risley, Nigel James Temperton, Othmar G. Engelhardt, Mary K. Collins, Yasuhiro Takeuchi, Simon E. Hufton · 2020 · Frontiers in Immunology
Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients
Teresa Aydillo, Alba Escalera, Shirin Strohmeier, Sadaf Aslam, Javier Sánchez‐Céspedes, Juan Ayllón, Cristina Roca-Oporto, Pilar Pérez‐Romero, Miguel Montejo, Joan Gavaldà et al. · 2020 · Cell Reports Medicine
Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for ‘Universal’ Influenza Vaccines
Maya Sangesland, Daniel Lingwood · 2021 · Vaccines
Immunotherapeutic strategies to target vulnerabilities in the Ebolavirus glycoprotein
John Misasi, Nancy J. Sullivan · 2021 · Immunity
Human cytomegalovirus antagonizes activation of Fcγ receptors by distinct and synergizing modes of IgG manipulation
Philipp Kolb, Katja Hoffmann, Annika Sievert, Henrike Reinhard, Eva Mercé-Maldonado, Vu Thuy Khanh Le‐Trilling, Anne Halenius, Dominique Gütle, Hartmut Hengel · 2021 · eLife
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge
Irene N. Nkumama, Rodney Ogwang, Dennis Odera, Fauzia K. Musasia, Kennedy Mwai, Lydia Nyamako, Linda Murungi, James Tuju, Kristin Fürle, Micha Rosenkranz et al. · 2024 · Immunity
Adenoviral vectors as novel vaccines for influenza
Lynda Coughlan, Caitlin E. Mullarkey, Sarah C. Gilbert · 2015 · Journal of Pharmacy and Pharmacology
Therapeutic Administration of Broadly Neutralizing FI6 Antibody Reveals Lack of Interaction Between Human IgG1 and Pig Fc Receptors
Sophie B. Morgan, Barbara Holzer, Johanneke Dinie Hemmink, Francisco Javier Salguero, John C. Schwartz, Gloria Agatic, Elisabetta Cameroni, Barbara Guarino, Emily Porter, Pramila Rijal et al. · 2018 · Frontiers in Immunology
Mini-HA Is Superior to Full Length Hemagglutinin Immunization in Inducing Stem-Specific Antibodies and Protection Against Group 1 Influenza Virus Challenges in Mice
Joan E. M. van der Lubbe, Johan W. A. Verspuij, Jeroen Huizingh, Sonja P. R. Schmit-Tillemans, Jeroen T. B. M. Tolboom, Liesbeth Dekking, Ted Kwaks, Boerries Brandenburg, Wim Meijberg, Roland C. Zahn et al. · 2018 · Frontiers in Immunology
The TLR4 agonist adjuvant SLA-SE promotes functional mucosal antibodies against a parenterally delivered ETEC vaccine
Hong Liang, David Poncet, Emilie Seydoux, Nicholas D. Rintala, Milton Maciel, Sophie Ruiz, Mark T. Orr · 2019 · npj Vaccines
Recombinant Influenza Vaccines: Saviors to Overcome Immunodominance
Nimitha R. Mathew, Davide Angeletti · 2020 · Frontiers in Immunology
Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay
Veronika Chromikova, Jessica Tan, Sadaf Aslam, Arvind Rajabhathor, Maria Carolina Bermúdez-González, Juan Ayllón, Viviana R. Simon, Adolfo García‐Sastre, Bruno Salaun, Raffael Nachbagauer et al. · 2020 · Vaccine
Study of rubella candidate vaccine based on a structurally modified plant virus
Ekaterina A. Trifonova, Vladimir A. Zenin, Nikolai A. Nikitin, Maria S. Yurkova, Ekaterina M. Ryabchevskaya, Egor V. Putlyaev, Ekaterina K. Donchenko, Olga A. Kondakova, Alexey N. Fedorov, Joseph G. Atabekov et al. · 2017 · Antiviral Research
In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections
Chasity D. Andrews, Yang Luo, Ming Sun, Jian Yu, Arthur J. Goff, Pamela J. Glass, Neal N. Padte, Yaoxing Huang, David D. Ho · 2017 · Molecular Therapy — Methods & Clinical Development
Immunological responses to influenza vaccination: lessons for improving vaccine efficacy
Taia T. Wang, Stylianos Bournazos, Jeffrey V. Ravetch · 2018 · Current Opinion in Immunology
Antibody Determinants of Influenza Immunity
James E. Crowe · 2019 · The Journal of Infectious Diseases
Influenza Vaccines: A Moving Interdisciplinary Field
Michael Schotsaert, Adolfo García‐Sastre · 2014 · Viruses
Fc Receptors in Antimicrobial Protection
Andreas Wieland, Rafi Ahmed · 2019 · Current topics in microbiology and immunology
Light chain modulates heavy chain conformation to change protection profile of monoclonal antibodies against influenza A viruses
Haixia Xiao, Tianling Guo, Mi Young Yang, Jianxun Qi, Chaobin Huang, Yuanyuan Hong, Jinjin Gu, Xuefei Pang, William Jun Liu, Ruchao Peng et al. · 2019 · Cell Discovery
Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From Quillaja brasiliensis Enhances Anti-Zika Immune Responses, Including Neutralizing Antibodies and Splenocyte Proliferation
Samuel Paulo Cibulski, Ana Paula Muterle Varela, Thais Fumaco Teixeira, Martín Cancela, Patrícia Sesterheim, Diogo Onofre Souza, Paulo Michel Roehe, Fernando L. Silveira · 2021 · Frontiers in Immunology
Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
Bronwyn M. Gunn, Shuangyi Bai · 2021 · Human Vaccines & Immunotherapeutics
Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase
Felix Broecker, Allen Zheng, Nungruthai Suntronwong, Weina Sun, Mark J. Bailey, Florian Krammer, Peter Palese · 2019 · Journal of Virology
The lipid globotriaosylceramide promotes germinal center B cell responses and antiviral immunity
Pankaj Sharma, Xiaolong Zhang, Kevin Ly, Yuxiang Zhang, Yu Hu, Adam Yongxin Ye, Jianqiao Hu, Ji Hyung Kim, Mumeng Lou, Chong Wang et al. · 2024 · Science
Antibody-Dependent Cell-Mediated Cytotoxicity to Hemagglutinin of Influenza A Viruses After Influenza Vaccination in Humans
Weimin Zhong, Feng Liu, Jason R. Wilson, Crystal Holiday, Zhu‐Nan Li, Yaohui Bai, Wen‐Pin Tzeng, James Stevens, Ian A. York, Min Z. Levine · 2016 · Open Forum Infectious Diseases
The Magnitude and IgG Subclass of Antibodies Elicited by Targeted DNA Vaccines Are Influenced by Specificity for APC Surface Molecules
Ranveig Braathen, Heidi Cecilie Larsen Spång, Mona M. Lindeberg, Even Fossum, Gunnveig Grødeland, Agnete Brunsvik Fredriksen, Bjarne Bogen · 2018 · ImmunoHorizons
Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap
Philipp A. Ilinykh, Rodrigo I. Santos, Bronwyn M. Gunn, Natalia A. Kuzmina, Xiaoli Shen, Kai Huang, Pavlo Gilchuk, Andrew I. Flyak, Patrick M. Younan, Galit Alter et al. · 2018 · PLoS Pathogens
An Influenza Virus Entry Inhibitor Targets Class II PI3 Kinase and Synergizes with Oseltamivir
Ryan O’Hanlon, Victor Hugo Leyva-Grado, Marion Sourisseau, Matthew J. Evans, Megan L. Shaw · 2019 · ACS Infectious Diseases
Differential immune imprinting by influenza virus vaccination and infection in nonhuman primates
Kevin R. McCarthy, Tarra A. Von Holle, Laura L. Sutherland, Thomas H. Oguin, Gregory D. Sempowski, Stephen C. Harrison, Michael Anthony Moody · 2021 · Proceedings of the National Academy of Sciences
Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2
Michael D. Grant, Kirsten Bentley, Ceri Alan Fielding, Keeley M. Hatfield, Danielle P. Ings, Debbie O. A. Harnum, Eddie C. Y. Wang, Richard James Stanton, Kayla A. Holder · 2023 · JCI Insight
Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead
Everardo Gonzalez‐González, Mario Moisés Álvarez, Alan Roberto Márquez-Ipiña, Grissel Trujillo‐de Santiago, Luis M. Rodríguez‐Martínez, Nasim Annabi, Ali Khademhosseini · 2015 · Critical Reviews in Biotechnology
Dissection of Epitope-Specific Mechanisms of Neutralization of Influenza Virus by Intact IgG and Fab Fragments
James A. Williams, Long Gui, Nancy Hom, Alexander Mileant, Kelly K. Lee · 2017 · Journal of Virology
IgG Fc Receptors: Evolutionary Considerations
Stylianos Bournazos · 2019 · Current topics in microbiology and immunology
The Vestigial Esterase Domain of Haemagglutinin of H5N1 Avian Influenza A Virus: Antigenicity and Contribution to Viral Pathogenesis
Zhiqiang Zheng, Subha Sankar Paul, Xiaobing Mo, Yuren Adam Yuan, Yee‐Joo Tan · 2018 · Vaccines
Neuraminidase delivered as an APC-targeted DNA vaccine induces protective antibodies against influenza
Ina Charlotta Werninghaus, Daniëla Maria Hinke, Even Fossum, Bjarne Bogen, Ranveig Braathen · 2023 · Molecular Therapy
From Variation of Influenza Viral Proteins to Vaccine Development
Wandi Zhu, Chao Wang, Bao‐Zhong Wang · 2017 · International Journal of Molecular Sciences
Age and Influenza-Specific Pre-Vaccination Antibodies Strongly Affect Influenza Vaccine Responses in the Icelandic Population whereas Disease and Medication Have Small Effects
Thorunn Asta Olafsdottir, Kristjan F. Alexandersson, Garðar Sveinbjörnsson, Giulia Lapini, Laura Palladino, Emanuele Montomoli, Giuseppe Del Giudice, Daniel Fannar Gudbjartsson, Ingileif Jónsdóttir · 2018 · Frontiers in Immunology
Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivo
Shamir R. Jacobino, Maaike Nederend, Josephine F. Reijneveld, Daan Augustijn, J.H. Marco Jansen, Jan Meeldijk, Karli R. Reiding, Manfred Wuhrer, Frank E. J. Coenjaerts, C. Erik Hack et al. · 2018 · mAbs
Mini-hemagglutinin vaccination induces cross-reactive antibodies in pre-exposed NHP that protect mice against lethal influenza challenge
Joan E. M. van der Lubbe, Jeroen Huizingh, Johan W. A. Verspuij, Lisanne Tettero, Sonja P. R. Schmit-Tillemans, Petra Mooij, Daniëlla Mortier, Gerrit Koopman, Willy M J M Bogers, Liesbeth Dekking et al. · 2018 · npj Vaccines
Development of a universal influenza vaccine using hemagglutinin stem protein produced from Pichia pastoris
Shih-Chi Wang, Hsin-Yu Liao, Jiayan Zhang, Ting-Jen Rachel Cheng, Chi‐Huey Wong · 2018 · Virology
Tissues: the unexplored frontier of antibody mediated immunity
Nicholas E. Webb, Biana Bernshtein, Galit Alter · 2021 · Current Opinion in Virology
Highly individual patterns of virus-immune IgG effector responses in humans
Eugenia Corrales‐Aguilar, Mirko Trilling, Henrike Reinhard, Valeria Falcone, Albert Zimmermann, Ortwin Adams, Sabine Santibanez, Hartmut Hengel · 2016 · Medical Microbiology and Immunology
Understanding Fc function for rational vaccine design against pathogens
Kathryn A. Bowman, Paulina Kapłonek, Ryan P. McNamara · 2023 · mBio
Fc‐ FcγR interactions during infections: From neutralizing antibodies to antibody‐dependent enhancement
Julia E. Edgar, Stylianos Bournazos · 2024 · Immunological Reviews
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
Joseph Paul Casazza, Amelia Ruth Hofstetter, Pamela J. M. Costner, LaSonji A. Holman, Cynthia Starr Hendel, Alicia T. Widge, Richard Licheng Wu, William R Whalen, Jennifer Cunningham, Anita Arthur et al. · 2024 · npj Vaccines
Development of an influenza virus protein microarray to measure the humoral response to influenza virus infection in mallards
Philip S. Meade, Neus Latorre‐Margalef, David E. Stallknecht, Florian Krammer · 2017 · Emerging Microbes & Infections
Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice
Jiong Wang, Shannon P. Hilchey, Marta L. DeDiego, Sheldon Perry, Ollivier Hyrien, Aitor Nogales, Jessica Garigen, Fatima Amanat, Nelson Huertas, Florian Krammer et al. · 2018 · PLoS ONE
Ebola Immunity: Gaining a Winning Position in Lightning Chess
Aurélie Ploquin, Yan Zhou, Nancy J. Sullivan · 2018 · The Journal of Immunology
Dendritic Cells TargetingLactobacillus plantarumStrain NC8 with a Surface-Displayed Single-Chain Variable Fragment of CD11c Induce an Antigen-Specific Protective Cellular Immune Response
Jing Liu, Guilian Yang, Haibin Huang, Chunwei Shi, Xing Gao, Wentao Yang, Zhang Zan, Yang Liu, Ke Xu, Jianzhong Wang et al. · 2019 · Infection and Immunity
Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice
Yonghong Liu, Shirin Strohmeier, Irene González‐Domínguez, Jessica Tan, Viviana R. Simon, Florian Krammer, Adolfo García‐Sastre, Peter Palese, Weina Sun · 2021 · Frontiers in Immunology
Broad neutralizing antibody-based strategies to tackle influenza
Xiaoyu Sun, Zhiyang Ling, Zhuo Ru Yang, Bing Sun · 2022 · Current Opinion in Virology
The role of Fc receptors in HIV infection and vaccine efficacy
Sarah L. Cocklin, Jörn E. Schmitz · 2014 · Current Opinion in HIV and AIDS
Roles of Fc Domain and Exudation in L2 Antibody-Mediated Protection against Human Papillomavirus
Joshua W. Wang, Wai Hong Wu, Tsui‐Chin Huang, Margaret Wong, Kihyuck Kwak, Keiko Ozato, Chien‐Fu Hung, Richard B. S. Roden · 2018 · Journal of Virology
Inactivated Influenza Vaccines
Joseph Bresee, Alicia M. Fry, Suryaprakash R. Sambhara, Nancy J. Cox · 2017 · Elsevier eBooks
Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses
Yo Han Jang, Baik Lin Seong · 2021 · Vaccines
Passive immunization with influenza haemagglutinin specific monoclonal antibodies
Rajeev Rudraraju, Kanta Subbarao · 2018 · Human Vaccines & Immunotherapeutics
The Potential Role of Fc-Receptor Functions in the Development of a Universal Influenza Vaccine
Sinthujan Jegaskanda · 2018 · Vaccines
Epigallocatechin-3-Gallate as a Novel Vaccine Adjuvant
Yucheol Cheong, Minjin Kim, Jina Ahn, Hana Oh, Jongkwan Lim, Wonil Chae, Seung Won Yang, Min‐Seok Kim, Ji Eun Yu, Sanguine Byun et al. · 2021 · Frontiers in Immunology
Influenza B: Prospects for the Development of Cross-Protective Vaccines
Liudmila M. Tsybalova, Liudmila A. Stepanova, Edward Smith Ramsay, Andrey V. Vasin · 2022 · Viruses
Intravenous immunoglobulin in kidney transplantation
Fasika M. Tedla, Andrea Roche-Recinos, Amarpali Brar · 2015 · Current Opinion in Organ Transplantation
AS03-Adjuvanted H5N1 Avian Influenza Vaccine Modulates Early Innate Immune Signatures in Human Peripheral Blood Mononuclear Cells
Leigh M. Howard, Johannes B. Goll, Travis Lee Jensen, Kristen L. Hoek, Nripesh Prasad, Casey E. Gelber, Shawn Levy, Sebastian Joyce, Andrew J. Link, Clarence Buddy Creech et al. · 2018 · The Journal of Infectious Diseases
Influenza vaccination strategies targeting the hemagglutinin stem region
Hidehiro Fukuyama, Ryo Shinnakasu, Tomohiro Kurosaki · 2020 · Immunological Reviews